Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APGB
976
DELISTED
Apollo Strategic Growth Capital II
APGB
| $3.14M | ﹤0.01% |
313,762
-96,260
| -23% | -$960K |
|
977
Lantheus
LNTH
$6.51B
| $3.11M | ﹤0.01% |
61,116
+36,306
| +146% | +$2.24M |
|
978
Zimmer Biomet
ZBH
$18.1B
| $3.1M | ﹤0.01% |
24,333
-24,337
| -50% | -$2.82M |
|
|
SHAP
979
DELISTED
Spree Acquisition Corp. 1 Limited
SHAP
| $3.08M | ﹤0.01% |
300,000
-300,000
| -50% | -$3.05M |
|
980
Tractor Supply
TSCO
$16.1B
| $3.04M | ﹤0.01% |
67,580
-59,590
| -47% | -$2.53M |
|
|
NVAC
981
DELISTED
NorthView Acquisition Corporation Common Stock
NVAC
| $3.01M | ﹤0.01% |
296,165
-3,835
| -1% | -$38.4K |
|
982
Nexstar Media Group
NXST
$5.83B
| $3.01M | ﹤0.01% |
17,186
-17,932
| -51% | -$3.15M |
|
983
Raymond James Financial
RJF
$33.7B
| $3.01M | ﹤0.01% |
28,137
-28,143
| -50% | -$3.16M |
|
|
VMW
984
DELISTED
VMware, Inc
VMW
| $3.01M | ﹤0.01% |
24,482
-24,486
| -50% | -$2.82M |
|
985
eBay
EBAY
$50.6B
| $2.99M | ﹤0.01% |
72,081
-79,095
| -52% | -$3.28M |
|
986
FS KKR Capital
FSK
$2.95B
| $2.98M | ﹤0.01% |
170,500
-745,768
| -81% | -$13.9M |
|
987
Alarm.com
ALRM
$2.69B
| $2.98M | ﹤0.01% |
60,250
-63,194
| -51% | -$3.48M |
|
|
BNNR
988
DELISTED
Banner Acquisition Corp. Class A Common Stock
BNNR
| $2.98M | ﹤0.01% |
295,457
-264,543
| -47% | -$2.64M |
|
989
Coupang
CPNG
$29.3B
| $2.93M | ﹤0.01% |
198,951
+119,955
| +152% | +$2.12M |
|
990
Diamondback Energy
FANG
$56.9B
| $2.92M | ﹤0.01% |
21,331
-21,335
| -50% | -$3.12M |
|
991
Ulta Beauty
ULTA
$22B
| $2.92M | ﹤0.01% |
6,215
+500
| +9% | +$216K |
|
992
Watsco Inc
WSO
$12.8B
| $2.91M | ﹤0.01% |
11,679
-10,357
| -47% | -$2.72M |
|
993
Vulcan Materials
VMC
$35.1B
| $2.91M | ﹤0.01% |
16,594
-16,656
| -50% | -$2.85M |
|
994
Trade Desk
TTD
$8.45B
| $2.91M | ﹤0.01% |
64,809
-48,775
| -43% | -$2.47M |
|
995
Five Below
FIVE
$11.9B
| $2.9M | ﹤0.01% |
16,419
-16,447
| -50% | -$2.59M |
|
996
Corcept Therapeutics
CORT
$12.3B
| $2.9M | ﹤0.01% |
142,815
-711,511
| -83% | -$17.8M |
|
997
Blue Owl Capital
OBDC
$5.34B
| $2.89M | ﹤0.01% |
+250,571
| New | +$3M |
|
998
Old Republic International
ORI
$10.5B
| $2.89M | ﹤0.01% |
119,695
-41,777
| -26% | -$980K |
|
999
AMN Healthcare
AMN
$1.31B
| $2.88M | ﹤0.01% |
27,990
-31,510
| -53% | -$3.63M |
|
1000
Sabra Healthcare REIT
SBRA
$5.35B
| $2.88M | ﹤0.01% |
231,280
-231,288
| -50% | -$2.95M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.